News for Teva Pharmaceutical Industries Limited (TEVA.TA)

We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Substack by Kontra. In this article, we will summarize the bulls’ thesis on TEVA.

We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Substack by Kontra. In this article, we will summarize the bulls’ thesis on TEVA. Teva Pharmaceutical Industries Limited (TEVA)’s share was trading at $13.94 as of April 7th. TEVA’s trailing and forward P/E were 872 and 5.37 respectively according to Yahoo Finance. After years […]

PR NewswireNEW YORK, March 17, 2025 NEW YORK, March 17, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Corcept Thera

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Leerink's 2025 Global Healthcare Conference March 12, 2025 8:40 AM ETCompany ParticipantsRichard Francis...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Barclays 27th Annual Global Healthcare Conference March 11, 2025 8:00 AM ETCompany ParticipantsRichard...

PR NewswireNEW YORK, March 3, 2025 NEW YORK, March 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Corcept Therapeu

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts.

Healthcare, which includes numerous businesses that offer patient care, conduct research and development of novel treatments, and design, produce, and distribute diagnostic tools and tests, takes the ...

We recently compiled a list of the Top 12 Stocks to Buy According to Bourgeon Capital. In this article, we are going to take a look at where Teva Pharmaceutical Industries Limited (NYSE:TEVA) stands ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Duvakitug (Anti-TL1A) Phase 2 Investors Call to Discuss New Data Presented at ECCO Conference February...

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling around 1% on Wednesday. The Dow traded down 0.16% to 44,778.55 while the ...

U.S. stocks traded mostly lower midway through trading, with the Nasdaq Composite falling more than 100 points on Wednesday. The Dow traded up 0.02% to 44,859....

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2024 Earnings Conference Call January 29, 2025 8:00 AM ETCompany ParticipantsChristopher Stevo - SVP,...

U.S. stock futures were mixed this morning, with the Nasdaq futures gaining around 0.4% on Wednesday. Shares of Manhattan Associates, Inc. MANH fell sharply in...

The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with their 2024 Q4 earnings call.

Piper Sandler analyst maintains an Overweight rating on Teva, citing positive feedback on duvakitug's potential in treating IBD.

Teva Pharmaceutical Industries Limited (NYSE:TEVA) 43rd Annual J.P.

Wall Street experienced a positive start to the Santa Rally season, with all major indices and sectors closing higher in the session ahead of Christmas.

We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Substack by Kontra. In this article, we will summarize the bulls’ thesis on TEVA.